Literature DB >> 10416675

Polymers of malic acid and 3-alkylmalic acid as synthetic PHAs in the design of biocompatible hydrolyzable devices.

S Cammas1, M M Béar, L Moine, R Escalup, G Ponchel, K Kataoka, P Guérin.   

Abstract

Poly(beta-malic acid) and poly(beta-3-alkylmalic acid) derivatives, as synthetic polyhydroxyalkanoates (PHAs), present several advantages as macromolecular materials for temporary biomedical applications. Indeed, such polymers, which can be synthesized through different chemical and biological routes, have cleavable ester bonds in their backbone for hydrolytic degradation, stereogenic centres in the monomers units for controlling the macromolecular structure. bioassimilable or non-toxic repeating units and lateral chemical functions which can be adapted to specific requirements. The strategy for building such complex architectures, with one or several specific pendant groups, is based on the anionic ring-opening polymerization or copolymerization of the large family of malolactonic and 3-alkylmalolactonic acid esters. Because we are able to control the monomer synthesis and the polymerization step, we have been able to prepare different degradable materials for the biomedical field, such as: degradable associating networks made up by the association of random copolyesters containing a small percentage of hydrophobic moieties and beta-cyclodextrin copolymers; degradable macromolecular micelles constituted by degradable amphiphilic block copolymers of poly(beta-malic acid) as hydrophilic segments and poly(beta-alkylmalic acid alkyl esters) as hydrophobic blocks; and degradable nanoparticles made up by hydrophobic poly(beta-malic acid alkyl esters) derivatives. We have also prepared a terpolymer which exhibits growth factor-like properties in vivo. Finally, poly(beta-malic acid) has been used as an additive in the preparation of peritoneal dialysis bags.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10416675     DOI: 10.1016/s0141-8130(99)00042-2

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  12 in total

1.  Nanoparticle systems for the targeted release of active principles of proteic nature.

Authors:  R Solaro; F Chiellini; F Signori; C Fiumi; R Bizzarri; E Chiellini
Journal:  J Mater Sci Mater Med       Date:  2003-08       Impact factor: 3.896

Review 2.  Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery.

Authors:  Julia Y Ljubimova; Manabu Fujita; Alexander V Ljubimov; Vladimir P Torchilin; Keith L Black; Eggehard Holler
Journal:  Nanomedicine (Lond)       Date:  2008-04       Impact factor: 5.307

3.  Brain tumor tandem targeting using a combination of monoclonal antibodies attached to biopoly(beta-L-malic acid).

Authors:  Manabu Fujita; Bong-Seop Lee; Natalya M Khazenzon; Manuel L Penichet; Kolja A Wawrowsky; Rameshwar Patil; Hui Ding; Eggehard Holler; Keith L Black; Julia Y Ljubimova
Journal:  J Control Release       Date:  2007-06-05       Impact factor: 9.776

Review 4.  Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?

Authors:  Babak Kateb; Katherine Chiu; Keith L Black; Vicky Yamamoto; Bhavraj Khalsa; Julia Y Ljubimova; Hui Ding; Rameshwar Patil; Jose Antonio Portilla-Arias; Mike Modo; David F Moore; Keyvan Farahani; Michael S Okun; Neal Prakash; Josh Neman; Daniel Ahdoot; Warren Grundfest; Shouleh Nikzad; John D Heiss
Journal:  Neuroimage       Date:  2010-02-10       Impact factor: 7.400

Review 5.  History of cyclodextrin-based polymers in food and pharmacy: a review.

Authors:  Max Petitjean; Iñigo X García-Zubiri; José Ramón Isasi
Journal:  Environ Chem Lett       Date:  2021-04-23       Impact factor: 9.027

6.  In Vitro Antiplasmodial and Cytotoxic Activities of Compounds from the Roots of Eriosema montanum Baker f. (Fabaceae).

Authors:  Jean Claude Didelot Tomani; Olivier Bonnet; Alain Nyirimigabo; William Deschamps; Alembert Tiabou Tchinda; Olivia Jansen; Allison Ledoux; Marie Jeanne Mukazayire; Luc Vanhamme; Michel Frédérich; Raymond Muganga; Jacob Souopgui
Journal:  Molecules       Date:  2021-05-10       Impact factor: 4.411

Review 7.  Application of nanoparticles on diagnosis and therapy in gliomas.

Authors:  Norma Y Hernández-Pedro; Edgar Rangel-López; Roxana Magaña-Maldonado; Verónica Pérez de la Cruz; Abel Santamaría del Angel; Benjamín Pineda; Julio Sotelo
Journal:  Biomed Res Int       Date:  2013-04-18       Impact factor: 3.411

8.  Development of Biocompatible and Functional Polymeric Nanoparticles for Site-Specific Delivery of Radionuclides.

Authors:  Nicolas Lepareur; Loleh Leal E Costa; Maëva Bocqué; Clément Blondelle; Clément Ruello; Marie Desjulets; Nicolas Noiret; Sandrine Cammas-Marion
Journal:  Front Med (Lausanne)       Date:  2015-09-04

Review 9.  Advances in the applications of polyhydroxyalkanoate nanoparticles for novel drug delivery system.

Authors:  Anupama Shrivastav; Hae-Yeong Kim; Young-Rok Kim
Journal:  Biomed Res Int       Date:  2013-07-24       Impact factor: 3.411

10.  Fabrication and Characterization of an Electrospun PHA/Graphene Silver Nanocomposite Scaffold for Antibacterial Applications.

Authors:  Abdul Mukheem; Kasturi Muthoosamy; Sivakumar Manickam; Kumar Sudesh; Syed Shahabuddin; Rahman Saidur; Noor Akbar; Nanthini Sridewi
Journal:  Materials (Basel)       Date:  2018-09-10       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.